Invesco »

Inozyme Pharma shares owned by Invesco

Quarter-by-quarter ownership of Inozyme Pharma (INZY) shares owned by Invesco from 13F filings

Historical chart of Invesco investment in Inozyme Pharma

Tip: Access up to 7 years of quarterly data

All positions including Inozyme Pharma held by Invesco consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Inozyme Pharma by Invesco

Quarter filed Position value Share count Share price at filing
2023-09-30 $55k 13k 4.20
2023-06-30 $73k 13k 5.57

More positions owned by Invesco

Microsoft Corporation (MSFT)
Apple (AAPL)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
NVIDIA Corporation (NVDA)
Meta Platforms Cl A (META)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Exxon Mobil Corporation (XOM)
Visa Com Cl A (V)
Chevron Corporation (CVX)
UnitedHealth (UNH)
JPMorgan Chase & Co. (JPM)
Tesla Motors (TSLA)
Johnson & Johnson (JNJ)

View all positions for Invesco

Top funds holding Inozyme Pharma

Samlyn Capital
Eventide Asset Management
NEA Management Company
Vanguard Group
Sphera Funds Management
Samsara BioCapital
Blue Owl Capital Holdings
Millennium Management
Laurion Capital Management
Octagon Capital Advisors
Goldman Sachs Group
Kennedy Capital Management
Overbrook Management Corp.
Citadel Advisors
GSA Capital Partners

View all funds holding Inozyme Pharma